Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  FRESENIUS6CPRF       


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

FRESENIUS6CPRF : Fresenius Medical Care holds virtual General Meeting on August 27, 2020 - dividend proposal unchanged

share with twitter share with LinkedIn share with facebook
07/09/2020 | 09:55am EDT

Fresenius Medical Care, the world's leading provider of dialysis products and services, will hold its Annual General Meeting (AGM) on August 27, 2020 as a virtual event.

Originally, the AGM was scheduled for May 19, 2020. It had to be postponed due to the coronavirus pandemic. As it is currently impossible to predict for how long the restrictions for large public events will be in effect, Fresenius Medical Care will use the option provided by the German legislator to hold a virtual event to safeguard the health of shareholders, employees and service providers.

The proposed dividend by the General Partner and the Supervisory Board remains unchanged at EUR1.20 per share entitled to dividend.

Shareholders will be provided the possibility to follow the entire AGM on the internet. Fresenius Medical Care will include further details in the AGM invitation that is to be published in the Federal Gazette (Bundesanzeiger) and on the corporate website in July.

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,002 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 348,703 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).


This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.


Matthias Link

Tel: +49 6172 609-2872

Email: matthias.link@fmc-ag.com

(C) 2020 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.94% 65.58 Delayed Quote.-0.58%
share with twitter share with LinkedIn share with facebook
All news about FRESENIUS6CPRF
07/15FRESENIUS6CPRF : Fresenius Medical Care in Schweinfurt joins environmental pact ..
07/09FRESENIUS6CPRF : Fresenius Medical Care holds virtual General Meeting on August ..
06/16FRESENIUS6CPRF : Fresenius Medical Care expands production at St. Wendel plant i..
05/19VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of..
04/22Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi..
03/11FRESENIUS6CPRF : Bahria Town International hospital, Fatima Memorial hospital an..
02/24Vifor pharma and fresenius kabi create joint venture in china for i.v. iron p..
More news